Purpose: This study aimed to evaluate the usefulness of the axillary lymph node to primary breast tumor maximum standardized uptake value (SUVmax) ratio in 18 F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for predicting the presence of metastasis in axillary lymph nodes. Methods: Herein, 196 consecutive patients with breast cancer who underwent PET/CT before surgery from January 2009 to January 2013 were included. We calculated the axillary lymph node to primary breast tumor SUVmax ratio using PET/CT. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the ratio were compared with those of nodal SUVmax and axillary ultrasonography. Axillary node metastasis was confirmed with sentinel node biopsy or axillary dissection. Results: The SUVmax ratio (cutoff, 0.14; area under the curve, 0.741) had 55.4% sensitivity, 91.6% specificity, 76.6% PPV, and 80.5% NPV for predicting axillary node metastasis. No significant difference was observed in terms of predicting axillary node metastasis among the SUVmax ratio, nodal SUVmax, and ultrasonography. In the multivariate analysis, primary tumor size (p= 0.014), SUVmax of the primary tumor (p= 0.011), axillary ultrasonography findings, nodal SUVmax, and SUVmax ratio were significantly associated with lymph node metastasis (p< 0.001). Conclusion: The axillary lymph node to primary breast tumor SUVmax ratio predicted axillary lymph node metastasis, although no significant difference in diagnostic performance was observed between PET/CT and ultrasonography. The axillary lymph node to primary breast tumor SUVmax ratio may be considered an additional method for the preoperative evaluation of axillary lymph node status.
INTRODUCTION
Breast cancer is the most frequently diagnosed solid malignancy and the second leading cause of cancer-related death in women in Western countries [1] . Among several prognostic factors for breast cancer, lymph node metastasis is recognized as the most important factor associated with survival [2] . Although lymph node metastasis has prognostic value, the precise preoperative evaluation of metastasis is difficult. Although many prognostic factors predicting axillary lymph node metastasis are available [2] , a more precise method for predicting metastasis would be useful.
Traditionally, axillary lymph node dissection (ALND) has been the standard method for axillary nodal assessment; however, this procedure can cause numbness, limitation of motion, and lymphedema [3] . Therefore, sentinel lymph node biopsy (SNB) is widely accepted as a less invasive alternative to ALND for small primary tumors [4] .
Positron emission tomography/computed tomography (PET/CT) is a widely used diagnostic tool in several types of malignancies. Because of the enhanced diagnostic performance of PET/CT imaging compared to conventional imaging methods (such as ultrasound, bone scan, and CT alone), it has been used in a variety of settings, including as an approach to staging high-risk patients with early breast cancer [5] . In a recent study, PET/CT was found to be superior to conventional imaging for the detection of distant metastases in patients with untreated stage II or III breast cancer [5] . However, the use of PET/CT as a 93 cient sensitivity to replace SNB in the detection of axillary lymph node metastasis, but the high specificity of PET/CT is useful when lymph node metastasis is suspected [7, 8] . A full diagnostic PET/CT scan has good overall accuracy and high specificity with the potential to triage patients for SNB versus ALND [7] .
For the preoperative prediction of axillary lymph node status, visual assessment and semiquantitative analysis with maximum standard uptake value (SUVmax) cutoffs are used [9, 10] . However, no consistent data have been reported regarding the differentiation of benign from malignant lymph nodes [10] . SUV measurement can differ according to hospital protocols and can be influenced by factors including body composition, blood glucose level, length of the uptake period, and the partial volume effect. SUVmax in lymph nodes is related to the 18 F-fluorodeoxyglucose (FDG) avidity of the primary tumor [11, 12] . Therefore, the axillary lymph node to primary breast tumor SUVmax ratio might predict lymph node status more objectively than nodal SUVmax alone.
In this retrospective study, we assessed the predictive value of the SUVmax ratio in patients with primary breast carcinoma to evaluate whether the SUVmax ratio predicted occult axillary metastasis.
METHODS

Patients
From January 2009 to January 2013, 332 patients were diagnosed with breast cancer at Chungbuk National University Hospital, and 239 underwent PET/CT and breast ultrasonography before surgery.
Excluded from this group of 239 patients were 26 patients who received neoadjuvant chemotherapy, nine who were diagnosed with bilateral breast cancer, and 28 whose permanent biopsy showed ductal carcinoma in situ. Following these exclusions, study participants in- 
Axillary ultrasonography
Ultrasonographic evaluation of axillary lymph nodes was performed by two experienced radiologists with a 10-to 12-MHz linear transducer (Philips Medical Systems, Bothell, USA). If indeterminate, suspicious, or metastatic lymph nodes were detected in the axilla, transverse and longitudinal scans were performed. Longitudinal and transverse diameters and cortical thickness of the nodes were measured. In cases of multiple lymph nodes in the axilla, the most suspicious lymph node was evaluated. Positive findings included lymph nodes that showed: (1) concentric or eccentric cortical thickening of greater than 3 mm; (2) hilar compression and especially absence of the fatty hilum; or (3) length-to-width ratio less than 1.5. Axillary lymph nodes that exhibited any of the three findings were defined as suspicious for axillary lymph node metastasis [12, 13] .
PET/CT acquisition
PET/CT (GE Healthcare, Piscataway, USA) scans were performed after conventional breast and axilla imaging. Patients fasted for more than 6 hours before undergoing scanning, and the serum glucose concentration was below 200 mg/dL prior to 18 F-FDG administration.
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Statistical methods
The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of ultrasonography, SUVmax, and SUVmax ratio were calculated using SPSS version 12.0 (SPSS Inc., Chicago, USA For the nodal SUVmax method (cutoff, 1; area under the curve, Figure 2 ). The overall sensitivity of ultrasonography, SUVmax, and SUVmax ratio for predicting nodal status differed for each method according to breast cancer T stage (Table 4) .
DISCUSSION
We evaluated the utility of PET/CT for the detection of axillary lymph node metastases in patients with breast cancer undergoing SNB or ALND. The sensitivity of PET/CT is lower in patients with early breast cancer and clinically negative axillary nodes. In a prospective study, Veronesi et al [6] . compared preoperative PET imaging with SNB and reported a sensitivity of only 37% with PET imaging.
Gil-Rendo et al. [14] showed a sensitivity of 100% for detecting lymph node metastasis in patients with grade III malignancy and primary tumor SUVmax higher than 3.5. Straver et al. [15] reported a sensitivity of 97% with PET/CT for detecting axillary involvement. The sensitivity of PET/CT was 53.8% in the current study. The SUVmax of small lymph nodes with metastasis might be underestimated because of partial-volume effects and the limited resolution of PET/CT. Higher false negative rates were noted in patients with smaller tumors, which may result from the low SUVmax of metastatic axillary lymph nodes derived from primary breast cancers [16] . Our results also showed that PET/CT was more sensitive for larger tumors (T1 vs. T2, T3).
The low sensitivity and inability to detect micrometastases can be explained by the relatively low spatial resolution of PET. This imaging modality does not allow the detection of micrometastases found using serial sectioning and immunohistochemistry during the pathological assessment of sentinel nodes. Other factors that could influence the sensitivity of PET/CT include intrinsic tumor characteristics such as grade and type [6, 17] . These results suggest that SNB is superior to PET/CT in the detection of axillary metastasis in patients with early-stage breast cancer. In the present study, the specificity of PET/ CT was 93.9%, similar to the findings of other PET/CT studies [15, 18] .
SNB may not be necessary in patients with findings highly suspicious for axillary lymph node metastasis on PET/CT; these patients could undergo complete ALND as the primary procedure, an approach that would reduce time and costs.
Higher SUV correlates with a variety of adverse prognostic vari- Receiver operating characteristic curve for predicting axillary node metastasis in patients with breast cancer. No significant difference was seen in prediction of lymph node metastasis among axillary ultrasonography (A), lymph node maximum standard uptake value (SUVmax) (B), and SUVmax ratio (C) of axillary lymph node to primary breast tumor on positron emission tomography/computed tomography.
Prediction of Axillary Nodal Status Using PET/CT 97 ables, including high proliferation index, tumor grade, HER2 expression, ER negativity, and greater numbers of circulating tumor cells [19, 20] . However, no clear relationship was observed between SUVmax and ER status, HER2 overexpression, or Ki-67 in the present study, although a relationship was observed between SUVmax and tumor grade. High primary tumor SUVmax was related to large tumor size and nodal SUVmax, consistent with the findings of previous studies [21, 22] . In breast cancer, tumor histopathology indicates that lobular carcinoma is associated with lower FDG uptake than ductal carcinoma [21] . The results of the current study revealed no differences in FDG uptake of the primary cancer or lymph nodes according to histologic type. However, only 11 patients (5.6%) with invasive lobular carcinoma were included in this study. Studies with larger sample sizes are needed to determine statistical significance.
In a variety of malignancies, higher SUVmax at diagnosis is associated with inferior survival [23, 24] . In one study, a group of patients with high primary tumor SUVmax had significantly worse prognosis than a group with low primary tumor SUVmax. In another study, high nodal SUVmax showed a significant association with poor prognosis in patients with breast cancer [25, 26] . Consistent with these reports that primary tumor and nodal SUVmax are significantly associated with prognosis in patients with breast cancer, primary tumor and nodal SUVmax, and the SUVmax ratio, were significantly associated with lymph node metastasis in the present study. Analysis of the relationship between FDG uptake parameters and treatment outcomes and survival was beyond the scope of this study.
We compared ultrasonography with PET/CT in terms of the detection of occult axillary metastasis. No statistical differences were observed between the methods in the current study. Although SUVmax is a suitable method for PET/CT image quantification, it should be considered a semiquantitative method by visual assessment. We experienced some problems with objectivity in the detection and validation of lymph nodes on PET/CT in the present study, because we were unable to validate the assessment of lymph nodes with abnormal uptake as metastatic on the basis of pathological results. We considered SUVmax to indicate the status of the metastatic lymph node examined via SNB or ALND. We did not determine intraobserver or interobserver variability for SUVmax, a limitation inherent to the semiquantitative nature of this study. SUV measurements can be influenced by factors including body composition, blood glucose level, length of uptake period, partial volume, and protocols [10] . The optimal cutoff was 0.14 in the present study. However, no definite cutoff has been established for the SUVmax ratio. Further research is warranted to define specific cutoffs for the SUVmax ratio.
We evaluated the ability of the axillary lymph node to primary breast tumor SUVmax ratio to detect occult metastases. The results were in agreement with the findings of previous studies that demonstrated poor sensitivity of this approach for detecting axillary node metastases in early breast cancer [17, 27] . PET/CT did not have sufficient sensitivity to replace SNB in the detection of axillary lymph node metastasis. This study is one of the few conducted with the aim of assessing the predictive value of the SUVmax ratio in patients with breast cancer. The axillary lymph node to primary breast tumor SUVmax ratio might be a more objective method than axillary ultrasonography, which is operator-dependent, for predicting lymph node metastasis.
In conclusion, the present study revealed that the axillary lymph node to primary breast tumor SUVmax ratio could be used to predict lymph node metastasis, although no significant difference in diagnostic performance was observed between PET/CT and ultrasonography.
The axillary lymph node to primary breast tumor SUVmax ratio may be considered an additional method for the preoperative evaluation of axillary lymph node status.
